Investing.com -- Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) stock jumped 9.5% in Monday premarket trading after the company reported promising efficacy data for its cancer treatment CRB-701 in ...

Corbus Pharmaceuticals ( ($CRBP) ) has shared an announcement. On October 18, 2025, Corbus Pharmaceuticals announced data from its Phase 1/2 ...

Corbus Pharmaceuticals (CRBP) announced data from its Phase 1/2 clinical study of CRB-701 will be presented as a poster at the 2025 European ...

Corbus Pharmaceuticals announced results from its first-in-human dose escalation study of CRB-701, presented at the ASCO GU 2025 conference. This Phase 1 study assessed the efficacy and safety of ...

Jorge Martin’s representative travelled to Assen last week with a clear intention: to shake the hornet’s nest and push the stalled negotiations between Aprilia and the Spanish rider into a new phase.

Corbus Pharmaceuticals Holdings, Inc. has announced the release of an abstract for its first-in-human dose escalation clinical study of CRB-701 (SYS6002), which targets Nectin-4 in patients with ...

The star T Corona Borealis, abbreviated T CrB, experiences a nova explosion about once every 80 years. This happened last in 1946 when it reached second magnitude, equal in brightness to the Big ...

PUPUKEA (KHON2) — Many North Shore residents are starting to see a change in the landscape with palm trees being infested by the Coconut Rhinoceros Beetle. “I just kind of noticed how a lot of the ...

CRB’s Board of Directors has named President Ryan Schroeder as Chief Executive Officer. Schroeder succeeds CEO and CRB co-founder Jeff Biskup, who will remain on the Board of Directors and lead the ...

PENZBERG, Germany, May 21, 2025 (GLOBE NEWSWIRE) -- CRB, a leading global provider of sustainable engineering, architecture, construction, and consulting solutions for life sciences companies, today ...

ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a favorable safety and ...